Terms: = Gastric cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306
21 results:
1. Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse gastric cancer.
Liu ZX; Zhang XL; Zhao Q; Chen Y; Sheng H; He CY; Sun YT; Lai MY; Wu MQ; Zuo ZX; Wang W; Zhou ZW; Wang FH; Li YH; Xu RH; Qiu MZ
JAMA Netw Open; 2022 Dec; 5(12):e2245836. PubMed ID: 36484990
[TBL] [Abstract] [Full Text] [Related]
2. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract] [Full Text] [Related]
3. Spindle assembly checkpoint MAD2 and CDC20 overexpressions and cell-in-cell formation in gastric cancer and its precursor lesions.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2019 Mar; 85():174-183. PubMed ID: 30448220
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptomic analysis of cic and ATXN1L reveal a functional relationship exploited by cancer.
Wong D; Lounsbury K; Lum A; Song J; Chan S; LeBlanc V; Chittaranjan S; Marra M; Yip S
Oncogene; 2019 Jan; 38(2):273-290. PubMed ID: 30093628
[TBL] [Abstract] [Full Text] [Related]
5. miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer.
Yu Y; Yu X; Liu H; Song Q; Yang Y
Int J Mol Med; 2018 Aug; 42(2):998-1007. PubMed ID: 29786108
[TBL] [Abstract] [Full Text] [Related]
6. A double-edged sword: The world according to Capicua in cancer.
Tanaka M; Yoshimoto T; Nakamura T
Cancer Sci; 2017 Dec; 108(12):2319-2325. PubMed ID: 28985030
[TBL] [Abstract] [Full Text] [Related]
7. miR‑206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
Gong YC; Ren GL; Liu B; Li F; Zhao HP; Chen JB; Li YP; Yu HH
Oncol Rep; 2017 Sep; 38(3):1688-1694. PubMed ID: 28714026
[TBL] [Abstract] [Full Text] [Related]
8. Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (cic) loss to activation of the MAPK signalling cascade.
LeBlanc VG; Firme M; Song J; Chan SY; Lee MH; Yip S; Chittaranjan S; Marra MA
J Pathol; 2017 Jun; 242(2):206-220. PubMed ID: 28295365
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.
Kang DW; Yang ES; Noh YN; Hwang WC; Jo SY; Suh YA; Park WS; Choi KY; Min DS
J Pathol; 2017 Apr; 241(5):614-625. PubMed ID: 28008607
[TBL] [Abstract] [Full Text] [Related]
10. Inactivation of Capicua drives cancer metastasis.
Okimoto RA; Breitenbuecher F; Olivas VR; Wu W; Gini B; Hofree M; Asthana S; Hrustanovic G; Flanagan J; Tulpule A; Blakely CM; Haringsma HJ; Simmons AD; Gowen K; Suh J; Miller VA; Ali S; Schuler M; Bivona TG
Nat Genet; 2017 Jan; 49(1):87-96. PubMed ID: 27869830
[TBL] [Abstract] [Full Text] [Related]
11. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
[TBL] [Abstract] [Full Text] [Related]
12. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.
Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847
[TBL] [Abstract] [Full Text] [Related]
13. [Drinking mineral waters in rehabilitation of cancer patients].
Vladimirov VI; Laktionova AI; Polushina ND
Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (4):16-9. PubMed ID: 15449666
[TBL] [Abstract] [Full Text] [Related]
14. A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer.
Jefford M; Michael M; Rosenthal MA; Davis ID; Green M; McClure B; Smith J; Waite B; Zalcberg J
Invest New Drugs; 2004 Apr; 22(2):185-92. PubMed ID: 14739668
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of Ig/Ig two-component-determined circulating immune complexes (Tcic) provide new insights into host immunity.
Wang S; Yang T; Zhang J; Xiao S; Peng X
Int Immunopharmacol; 2003 Oct; 3(10-11):1549-55. PubMed ID: 12946452
[TBL] [Abstract] [Full Text] [Related]
16. [Immune status of the spleen and surgical treatment in patients with advanced gastric cancer].
Zhu Z
Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):330-3, 381. PubMed ID: 1332809
[TBL] [Abstract] [Full Text] [Related]
17. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
Xu RJ; Gu YA
J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
[TBL] [Abstract] [Full Text] [Related]
18. Pre-operative and post-operative evaluation of circulating immune complexes in patients with gastric adenocarcinoma.
Siddiqi MA; Salahuddin M; Shah OJ; Wani NA
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):95-8. PubMed ID: 2624669
[TBL] [Abstract] [Full Text] [Related]
19. [Circulating immune complex and cancer in the digestive system].
Wang YM
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):445-7. PubMed ID: 3836848
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of an enzyme-linked immunosorbent Raji cell assay (ELISA) in the investigation of gastrointestinal cancer.
Leveson SH; Woodhouse LF; Giles GR
Cancer Immunol Immunother; 1984; 16(3):186-8. PubMed ID: 6367966
[TBL] [Abstract] [Full Text] [Related]
[Next]
